Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in medical settings in EU Member States and Norway
Since 1996, following outbreaks of variant Creutzfeldt–Jakob disease (vCJD) in several Member States, both the European Union and individual countries have implemented special public health measures and renewed research efforts in the field of human and animal transmissible spongiform encephalopathies (TSEs).
The purpose of this report is to provide a review of available national documents aimed at controlling the transmission of human TSE in medical settings, taking the epidemiological situation and recent research results into account. The ultimate goal was to identify potential needs and tools useful to Member States for drawing up recommendations suited to their specific needs.
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
22 Jul 2021 - This document provides a review of evidence on three topics of interest (effectiveness of partial vaccination, immunogenicity and effectiveness of vaccination for previously infected individuals and safety and immunogenicity of heterologous schedules) to inform ongoing decision-making in relation to national vaccination policies and strategies in the European Union and European Economic Area (EU/EEA) countries.
COVID-19 in children and the role of school settings in transmission - second update
8 Jul 2021 - The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures.